2reverse splits
1-for-836 cumulative
+303.7%share growth, 1-year
XBRL EDGAR
13.4M → 2.3Mshares issued (XBRL history)
Quietfiling state
from EDGAR

Case Notes

Psyence Biomedical Ltd. has 2 reverse splits on record — cumulative 1-for-836. Its share count grew 303.7% over the last twelve months per XBRL EDGAR data.

No stress-language filings on record in our dataset. However, 1 supply registration (S-1/424B) appear in the last 12 months.

The current filing record is quiet: nothing newly registered, no recent stress flags. In our dataset, quiet is where every cycle began — the absence of filings is itself a data point, not a clearance. This record will be updated as new filings land on EDGAR.

Share Count Over Time

XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 2 reverse splits on record.

Reverse Split Log

Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.

2024-11-261-for-76.1
2025-05-051-for-11.0

Cumulative effective ratio: 1-for-836— a share held at inception is now worth 1/836 of its original fraction.

424B Supply Pulse

Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.

11 08 10 11 12 01 11
2023-112024-082024-102024-112024-122025-012025-11

← Back to Registry